Similar Items: Safety, efficacy, pharmacokinetics, and mechanisms of novel 10B‐boronophenylalanine combined with a radio‐frequency quadrupole accelerator in boron neutron capture therapy: A preclinical study in head and neck squamous cell carcinoma
- Boron‐10 carriers and their applications in boron neutron capture therapy
- Emerging Agents for Boron Neutron Capture Therapy: Biomolecular Carriers Paving the Way for Precision Radiotherapy
- Female sex is associated with worse survival in laryngeal head and neck squamous cell carcinoma
- COX5A promotes cell progression and cisplatin‐resistance by alleviating mitochondrial dysfunction in head and neck squamous cell carcinoma
- The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer
- Predicting Post‐Radiotherapy Epigenetic Age Acceleration From Pre‐Treatment Data Using a Machine Learning Framework in Head and Neck Cancer Patients